| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $9.4M | +49.6% |
| Cost of Revenue | $19.8M | +59.9% |
| Gross Profit | -$10.4M | -70.4% |
| R&D Expense | $351.6M | +22.4% |
| SG&A Expense | $127.1M | +7.6% |
| Operating Income | -$489.1M | -18.9% |
| Pre-tax Income | -$472.0M | +35.6% |
| Income Tax | $0 | — |
| Net Income | -$472.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $615.4M | -54.0% |
| Short-term Investments | $377.3M | — |
| Accounts Receivable | $1.4M | -13.9% |
| Current Assets | $1.01B | -25.5% |
| Total Assets | $1.07B | -23.1% |
| Current Liabilities | $71.5M | +27.9% |
| Long-term Debt | $3.7M | -33.8% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$329.9M | -27.3% |
| Capital Expenditures | $13.6M | +2.1% |
| Investing Cash Flow | -$392.2M | -2775.8% |
| Financing Cash Flow | $1.4M | -99.9% |
| Free Cash Flow | -$343.5M | -26.1% |
| +35.6% |
| EPS (Basic) | -$2.11 | +51.6% |
| EPS (Diluted) | -$2.11 | +51.6% |
| Total Liabilities |
| $119.8M |
| +72.8% |
| Stockholders' Equity | $954.5M | -28.1% |